SBC SBC Medical Group Holdings Inc

Overview and Growth

SBC Medical Group Holdings Inc generated $173.61M of revenue in fiscal 2025, with net income of $50.99M and an operating cash inflow of $24.67M. Revenue of $173.61M sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line contracted 15.5% from $205.42M in fiscal 2024; this top-line contraction left the company with a smaller revenue base. On a per-share basis, diluted EPS was $0.50, which connects the reported earnings outcome with the company’s diluted share count. The per-share result recorded a 4.2% increase from fiscal 2024 diluted EPS of $0.48. The revenue-to-assets relationship was 0.46x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $127.28M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. The gross-profit relationship equaled 73.3% of revenue, quantifying the portion retained before operating expenses were recognized. Operating income was $67.49M, the earnings remaining from reported operations after the company’s recognized operating cost structure. Relative to revenue, operating income represented 38.9%, showing how efficiently sales converted into operating profit. After all reported below-operating-line items, the company recorded net income of $50.99M for the fiscal year. Measured against reported revenue, net income produced a 29.4% margin after operating costs and the remaining recognized items. Pretax income was $82.07M, isolating the reported earnings outcome before the income-tax provision recognized for the fiscal year. Pretax income represented 47.3% of revenue, placing earnings before tax in the context of the company’s operating scale. The company recognized $31.02M of income tax for the period, completing the transition from pretax income to net income. The income-tax provision equaled 37.8% of pretax income, showing the tax burden absorbed by the year’s earnings.

Liquidity and Capital Structure

At period end, the $380.45M asset base was financed through $117.14M of liabilities and $263.30M of equity. At period end, current assets of $231.22M compared with current liabilities of $61.12M, defining the company’s short-term resource position. Current assets covered current liabilities by 3.78x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $163.77M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 268.0% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $43.06M, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 0.16x, showing how much debt the company carried for each unit of book equity. Debt represented 11.3% of total assets, placing borrowing in the context of the company’s full resource base. The liabilities-to-assets relationship was 30.8%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 43.0%, comparing reported cash and equivalents with the full positive asset balance.

Cash Flow and Earnings Quality

Cash flow from operations was $24.67M, a reported cash inflow that can be compared directly with net income and capital spending. Operating cash flow equaled 0.48x of net income, showing how strongly accounting earnings converted into cash from operations. Capital expenditures used $1.40M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Relative to operating cash flow, capital expenditures measured 5.7%, connecting investment intensity with the company’s cash-generation base. The combination of operating cash flow and capital spending produced $23.27M of positive free cash flow for the period. Free cash flow represented 13.4% of revenue, linking post-investment cash generation with the company’s operating scale. The free-cash-flow-to-assets relationship was 6.1%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.